| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Urology [N. S., T. K.] and Biochemistry Laboratory, Cancer Institute [S. G., K. K., A. M.], Hokkaido University School of Medicine, Sapporo 060, Japan
Lactosylceramide sulfate and galactosylceramide sulfate were found to increase markedly in human renal cell carcinoma (adenocarcinoma) as compared to uninvolved tissue. Activities of two sulfotransferases toward galactosylceramide and lactosylceramide as substrates were significantly elevated in the carcinoma compared to the uninvolved tissue resulting in enhanced synthesis of the two sulfatides in the carcinoma. The elevation of the two sulfotransferases was parallel in most tumors, suggesting that the same enzyme is responsible for the enhanced synthesis of two sulfatides. No consistent difference in the activity of arylsulfatase A, which desulfates the two sulfatides, was observed between the carcinoma and uninvolved tissue.
Both the present and previous results show that the increased synthesis of the sulfatide(s) due to elevated sulfotransferase activity could be a biochemical characteristic common to adenocarcinomas derived from different tissues.
1 Supported by Grants-in-Aid from the Ministry of Education, Science and Culture, the Akiyama Foundation, the Daiwa Health Foundation, and the Snow Brand Milk Products Company, Japan.
2 To whom requests for reprints should be addressed.
Received 5/23/88. Revised 9/19/88. Accepted 10/13/88.
This article has been cited by other articles:
![]() |
Z. V. Popovic, R. Sandhoff, T. P. Sijmonsma, S. Kaden, R. Jennemann, E. Kiss, E. Tone, F. Autschbach, N. Platt, E. Malle, et al. Sulfated Glycosphingolipid as Mediator of Phagocytosis: SM4s Enhances Apoptotic Cell Clearance and Modulates Macrophage Activity J. Immunol., November 15, 2007; 179(10): 6770 - 6782. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Garcia, N. Callewaert, and L. Borsig P-selectin mediates metastatic progression through binding to sulfatides on tumor cells Glycobiology, February 1, 2007; 17(2): 185 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kyogashima, K. Tamiya-Koizumi, T. Ehara, G. Li, R. Hu, A. Hara, T. Aoyama, and R. Kannagi Rapid demonstration of diversity of sulfatide molecular species from biological materials by MALDI-TOF MS Glycobiology, August 1, 2006; 16(8): 719 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Hebert, H. E. Smith, T. C. Marbury, S. K. Swan, W. B. Smith, R. W. Townsend, D. Buell, J. Keirns, and I. Bekersky Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction J. Clin. Pharmacol., October 1, 2005; 45(10): 1145 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Torii, M. Fukuta, and O. Habuchi Sulfation of sialyl N-acetyllactosamine oligosaccharides and fetuin oligosaccharides by keratan sulfate Gal-6-sulfotransferase Glycobiology, February 1, 2000; 10(2): 203 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Honke, M. Tsuda, Y. Hirahara, A. Ishii, A. Makita, and Y. Wada Molecular Cloning and Expression of cDNA Encoding Human 3'-Phosphoadenylylsulfate:galactosylceramide 3'-Sulfotransferase J. Biol. Chem., February 21, 1997; 272(8): 4864 - 4868. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |